Home > Press > Newbridge Announces Nanotechnology Index (NYSEArca: NNIX) Quarterly Rebalance
Abstract:
There were no NNIX constituent additions or deletions for Q307, keeping the total number of companies at 23 in the NNIX. Constituents subject to the 10% index weight cap remained the same except for Flamel Technologies (ADR-NasdaqGM: FLML), which, because of a substantial drop in its stock price of approximately 56%, was excluded from the index weight cap group. For the quarter ended August 16, 2007 the NNIX closed at 713.56, down 11.1% from its last rebalance, May 17, 2007 closing at 802.67.
Newbridge Securities Corporation announced the quarterly rebalancing and reconstitution of its Newbridge Nanotechnology Index (NYSEArca: NNIX).
There were no NNIX constituent additions or deletions for Q307, keeping the total number of companies at 23 in the NNIX. Constituents subject to the 10% index weight cap remained the same except for Flamel Technologies (ADR-NasdaqGM: FLML), which, because of a substantial drop in its stock price of approximately 56%, was excluded from the index weight cap group. For the quarter ended August 16, 2007 the NNIX closed at 713.56, down 11.1% from its last rebalance, May 17, 2007 closing at 802.67.
Significant events in the quarter included the split off of Combimatrix (NasdaqCM: CBMXD) from Acacia Research Corp. and the acquisition of Cambridge Display Technology (NasdaqGM: OLED) by Sumitomo Chemical Company of Japan. The redemption of Acacia Research-CombiMatrix common stock for common stock of CombiMatrix Corp., at a ratio of 10-1, reduced CombiMatrix's NNIX index weight from 0.65% to 0.41%, a decline of 36.9%. Sumitomo Chemical's acquisition of Cambridge Display, which is expected to be completed during the third or fourth quarter of 2007, offers Cambridge Display shareholders $12 per share in cash. The announcement, which was made last month, boosted Cambridge Display shares 89%. With the stock closing on Aug. 16 at $11.65 and virtually no change in OLED shares outstanding from Q207, the company's NNIX index weight increased from 2.02% to 4.83%.
The Newbridge Nanotechnology Index (NNIX) has been constructed to track the stock market performance of companies that are currently active in nanotechnology. The Index is comprised of companies whose operations, based on our assessment of products, intellectual property, research initiatives and partnerships, include a significant focus on nanotechnology. Companies whose market capitalizations are very large relative to the scope of their nanotechnology operations are not included in order to preserve the pure play nature of the Index. Only companies with common stock or ADRs listed on a national market or exchange in the U.S. are eligible. The base date for the Index is June 30, 2004, at which time the base value for the Index was set at 1000. The NNIX is market cap weighted, rebalanced quarterly, and now includes 23 companies.
####
About Newbridge Securities Corporation
Newbridge is a full-service securities brokerage firm (Member: NASD & SIPC) and a subsidiary of Newbridge Financial, Inc., an integrated financial services company. The Newbridge Institutional Research department specializes in the analysis and coverage of companies that have a strategic focus on nanotechnology. More information is available at our websites http://www.newbridgereports.com and http://www.newbridgesecurities.com .
For important disclosures please visit:
http://www.newbridgesecurities.com/research_rpt_discl.html Additional information is available upon request.
For more information, please click here
Contacts:
David M. Keiter
Director of Research
954-334-3450 x115.
Copyright © PRWeb™
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||